Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Juli

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Haematologica|February 22, 2020
Exploiting MYC-induced PARPness to target genomic instability in multiple myelomaDaniele Caracciolo, Francesca Scionti, Giada Juli, et al.
International Journal of Molecular Sciences|September 23, 2022
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple MyelomaKatia Grillone, Caterina Riillo, Roberta Rocca, et al.
Journal of Translational Medicine|May 4, 2023
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancerCaterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, et al.
Cancers|March 29, 2023
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone SarcomasNicoletta Polerà, Antonia Mancuso, Caterina Riillo, et al.
Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.
Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.
British Journal of Haematology|November 14, 2023
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphomaDaniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte, et al.
Scientific Reports|February 15, 2020
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver DiseaseVincenzo Musolino, Micaela Gliozzi, Federica Scarano, et al.
Experimental Hematology & Oncology|September 12, 2022
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström MacroglobulinemiaEugenio Morelli, Zachary R Hunter, Mariateresa Fulciniti, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Haematologica|February 22, 2020
Exploiting MYC-induced PARPness to target genomic instability in multiple myelomaDaniele Caracciolo, Francesca Scionti, Giada Juli, et al.
International Journal of Molecular Sciences|September 23, 2022
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple MyelomaKatia Grillone, Caterina Riillo, Roberta Rocca, et al.
Journal of Translational Medicine|May 4, 2023
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancerCaterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, et al.
Cancers|March 29, 2023
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone SarcomasNicoletta Polerà, Antonia Mancuso, Caterina Riillo, et al.
Leukemia|March 1, 2018
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activityNicola Amodio, Maria Angelica Stamato, Giada Juli, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 26, 2023
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myelomaFrancesca Scionti, Giada Juli, Roberta Rocca, et al.
Journal of Translational Medicine|October 23, 2022
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid RhamnetinDaniele Caracciolo, Giada Juli, Caterina Riillo, et al.
British Journal of Haematology|November 14, 2023
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphomaDaniele Caracciolo, Nicoletta Polerà, Beatrice Belmonte, et al.
Scientific Reports|February 15, 2020
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver DiseaseVincenzo Musolino, Micaela Gliozzi, Federica Scarano, et al.
Experimental Hematology & Oncology|September 12, 2022
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström MacroglobulinemiaEugenio Morelli, Zachary R Hunter, Mariateresa Fulciniti, et al.
Pageof 6